Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression
Author:
Funder
the National Institutes of Health grants
MedImmune
Publisher
American Society for Clinical Investigation
Subject
General Medicine
Link
https://www.jci.org/articles/view/96113/files/pdf
Reference42 articles.
1. Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
2. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
3. Expression of tumour-specific antigens underlies cancer immunoediting
4. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
5. Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
Cited by 379 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Immunotherapy for non-small cell lung cancer;Respiratory Investigation;2024-03
2. Pulmonary blastoma is successfully treated with immunotherapy and targeted therapy;Lung Cancer;2024-03
3. Laccase-inspired bi-amino acid MOFs with high substrate affinity: Catalytic deposition induced “signal-down” electrochemical response towards PD-L1;Sensors and Actuators B: Chemical;2024-01
4. Tumor-draining lymph nodes: opportunities, challenges, and future directions in colorectal cancer immunotherapy;Journal for ImmunoTherapy of Cancer;2024-01
5. Caught in the middle: MARCH5 mediates PD-1-induced IL-2R degradation;Cell Research;2023-12-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3